Showing results (231-240 of 372) with videos related to
Sort By:
Pageof 38
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1975
Interaction of prostaglandin A2 and prostaglandin B2 on vascular smooth muscle tone, vascular reactivity and electrolyte transportW R Wilson, S Greenberg, P J Kadowitz, et al.International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Nitrobenzyl mustard quaternary salts: a new class of hypoxia-selective cytotoxins capable of releasing diffusible cytotoxins on bioreductionW A Denny, W R Wilson, M Tercel, et al.International Journal of Radiation Oncology, Biology, Physics|July 1, 1986
Reductive metabolism and hypoxia-selective toxicity of nitracrineW R Wilson, W A Denny, G M Stewart, et al.Biochimica Et Biophysica Acta|March 31, 1988
Mechanism of resistance of non-cycling mammalian cells to 4'-[9-acridinylamino]methanesulphon-m-anisidide: role of DNA topoisomerase II in log- and plateau-phase CHO cellsE Schneider, S J Darkin, M A Robbie, et al.Journal of Medicinal Chemistry|August 28, 1999
5-Amino-1-(chloromethyl)-1,2-dihydro-3H-benz[e]indoles: relationships between structure and cytotoxicity for analogues bearing different DNA minor groove binding subunitsG J Atwell, J J Milbank, W R Wilson, et al.International Journal of Radiation Oncology, Biology, Physics|November 7, 1998
Extravascular diffusion of tirapazamine: effect of metabolic consumption assessed using the multicellular layer modelK O Hicks, Y Fleming, B G Siim, et al.Cancer Chemotherapy and Pharmacology|December 29, 2000
Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5P Kestell, F B Pruijn, B G Siim, et al.The Annals of Thoracic Surgery|September 11, 1991
The Damus-Stansel-Kaye procedure: anatomical determinants and modificationsS Y DeLeon, M N Ilbawi, K Tubeszewski, et al.British Journal of Cancer|May 21, 2009
E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954S O Vass, D Jarrom, W R Wilson, et al.The Journal of Clinical Investigation|September 1, 1975
Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenonJ J Lertora, A L Mark, J Johannsen, et al.Pageof 38